How to Buy Tenaya Therapeutics Stock
Tenaya Therapeutics Inc
Tenaya Therapeutics, Inc. , a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.
Tenaya Therapeutics stock last closed at $2.55, down 0.97% from the previous day, and has decreased 15.28% in one year. It has overperformed other stocks in the Biotechnology industry by 0.18 percentage points. Tenaya Therapeutics stock is currently +55.49% from its 52-week low of $1.64, and -68.48% from its 52-week high of $8.09.
At the moment, there are 67.87M shares of TNYA outstanding. The market cap of TNYA is $173.06M. In the last 24 hours, 915,574 TNYA shares were traded.
How to Buy Tenaya Therapeutics Stock
Not sure how to invest in Tenaya Therapeutics stock? Here's how.
- Choose where to buy Tenaya Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Tenaya Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Pick your method of payment and add your details.
- Analyze Tenaya Therapeutics stock: The Tenaya Therapeutics ticker symbol is TNYA. Is Tenaya Therapeutics stock a good investment? Should you buy shares of TNYA? How do TNYA's underlying business fundamentals look? Do top analysts think Tenaya Therapeutics is a good buy? Why has TNYA's stock price moved recently? (Hint: Our stock research tools can help you decide if TNYA is a good stock to buy).
- Execute your TNYA buy order: Decide if you will purchase TNYA shares at the current market price or use a limit order to purchase TNYA stock at a particular price.
- Get notifications regarding your TNYA position: Create a watchlist to watch your investment in Tenaya Therapeutics shares.
Step 1: Choose where to buy Tenaya Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy TNYA stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Real Estate, New York to London — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen your brokerage, the next step is to fill out some personal info so you are able to buy TNYA stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.
- Provide your personal details to open your new trading account.
- Send your application by hitting the "Create Account" button.
Step 3: Fund your brokerage account
Now that you have finished signing up on app for stock, you need to deposit funds:
Watch the walkthrough below for more details depositing money into your new investment account.
Step 4: Analyze Tenaya Therapeutics stock
After you have selected the best place to buy Tenaya Therapeutics stock, it's very important to analyze their stock prior to buying, so you truly understand the risk and opportunity.
Tenaya Therapeutics quick stats
Fundamentals of Tenaya Therapeutics
WallStreetZen was built to help average investors perform better fundamental analysis.
You can view all of the due diligence checks on TNYA's stock page.
What is the fair value of TNYA stock?
Investors use many financial metrics, analyses, models, and charts to gauge TNYA's fair value.
Using relative valuations methods:
- TNYA could be undervalued based on its P/B ratio of 0.91x, relative to Biotechnology industry P/B ratio of 5.09x
You can access more valuation analysis on TNYA's stock here.
TNYA Financial Overview
Signs that TNYA is financially healthy:
- TNYA has $132.51M in cash and short term investments. This is enough to cover its annual cash burn of $112.44M.
- There are more short-term assets than short-term liabilities on the TNYA balance sheet.
- TNYA has a low debt to equity ratio of 0.16.
- TNYA has cash burn of 112444000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the TNYA balance sheet.
Do Wall Street analysts think it's a good time to buy TNYA stock
Out of 4 sell side analysts who give ratings on TNYA, the consensus analyst rating on TNYA is a Strong Buy
Please note that analyst ratings are not recommendations, nor are they financial advice.
Most Recent TNYA Analyst Ratings
Geulah Livshits, a top 8% analyst from Chardan Capital reiterates TNYA with a strong buy rating and maintains their TNYA price target from $23.00 to $23.00, on Aug 14, 2023.
Whitney Ijem, a top 2% analyst from Canaccord Genuity maintains TNYA with a strong buy rating and lowers their TNYA price target from $18.00 to $17.00, on Aug 11, 2023.
Matthew Harrison, a bottom 3% analyst from Morgan Stanley maintains TNYA with a strong buy rating and raises their TNYA price target from $13.00 to $14.00, on Aug 10, 2023.
Joseph Pantginis, a bottom 1% analyst from HC Wainwright & Co. reiterates TNYA with a buy rating and maintains their TNYA price target from $18.00 to $18.00, on Aug 10, 2023.
You can dig deeper into what analysts are saying on the Tenaya Therapeutics stock forecast page.
Metrics for Advanced TNYA Traders
Latest Insiders Trades at TNYA
Over the last 12 months, executives and large shareholders at TNYA have bought more shares than they have sold.
Timothy Hoey, Chief Scientific Officer of TNYA, was the latest TNYA insider to sell. They sold $30,855.18 worth of TNYA shares on Aug 29, 2023.
Learn more about who owns TNYA stock here.
Can I rely on TNYA as an income stream?
No, Tenaya Therapeutics doesn't provide an income stream by paying out dividends.
TNYA Social Trading Data
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your TNYA buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific price limit, use a limit order.
Click the Open button and eToro will place your order.
If you need more help investing in stocks on eToro, watch the how to video below:
Step 6: Get notifications regarding your TNYA position
Now that you own some TNYA stock, you'll want to stay up-to-date on your new company.
Start a watchlist to see the latest developments about your TNYA stock.
TNYA Feed
How to Buy Stock in Tenaya Therapeutics
To reiterate, here are the 6 steps to buy stock in Tenaya Therapeutics:
- Choose where to buy Tenaya Therapeutics stock
- Sign up for your brokerage account
- Fund your brokerage account
- Analyze Tenaya Therapeutics stock
- Execute your TNYA buy order
- Get notifications regarding your TNYA position
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your investment in Tenaya Therapeutics, add TNYA to your watchlist below.
More "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.